MILLENNIUM MANAGEMENT LLC
Position in RVPH — Reviva Pharmaceuticals Holdings, Inc.
CIK 1273087
NEW YORK, NY
Position in RVPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$579,343
-$52,165 QoQ
Shares Held
793,948
-64.9% QoQ
Ownership
6.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVPH Over Time
Shares Held
Position Value (USD)
Derivatives in RVPH
reported options exposure · as of Dec 31, 2025CallValue
$277,381
CallShares
994,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,539,054 across 322 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in RVPH
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $579,343 | 793,948 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $277,381 | 994,200 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $631,508 | 2,263,470 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $630,756 | 1,711,221 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $567,093 | 1,488,043 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,463,431 | 1,534,317 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,266,123 | 1,804,488 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,639,252 | 1,832,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,589,111 | 1,241,493 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,230,376 | 854,597 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $280,675 | 54,500 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $4,129,815 | 801,906 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $732,000 | 150,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $2,064,884 | 423,132 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $586,000 | 100,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $2,693,701 | 459,676 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $161,042 | 38,435 | Shares | Sole | 2023-05-15 | |
| 2021-03-31 | $202,679 | 35,310 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||